Structure and Ligand-Based Drug Design to Propose Novel -Glucosidase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|5|2|99-109

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.5, Iss.2, 2009-06, pp. : 99-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ligand-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 112-123

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand-based Design of P-glycoprotein Inhibitors: A Historical Perspective

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4197-4214

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 22, 2012-08 ,pp. : 3763-3778

Bentham Science Publishers

Access to resources Recommend Favorite

Computer-Aided Drug Design: Integration of Structure-Based and Ligand-Based Approaches in Drug Design

By  

Current Computer - Aided Drug Design, Vol. 3, Iss. 2, 2007-06 ,pp. : 133-148

Bentham Science Publishers

Access to resources Recommend Favorite